Roch Houot

39PUBLICATIONS
200CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 16, 2026
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.

|May 12, 2026
Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma.

|Apr 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Vincent Camus, Daphné Krzisch, Alessio Bruscaggin

|Mar 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Nicolas Gower, Pierre Feugier, Jason R Westin

|Feb 24, 2026
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study.

Sarah Cayla, Lionel Karlin, Jérôme Lambert

|Jan 09, 2026
Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma.

Emilie Charton, Amélie Anota, Emmanuel Bachy

Pageof 7

Frequent Collaborators

17 joint publications

Emmanuel Bachy

13 joint publications

Franck Morschhauser

13 joint publications

Guillaume Cartron

13 joint publications

Sylvain Choquet